Association of Congenital and Acquired Cardiovascular Conditions With COVID-19 Severity Among Pediatric Patients in

Louis Ehwerhemuepha1, Bradley Roth2, Anita K Patel3

  • 1Children's Health of Orange County, Orange, California.

JAMA Network Open
|May 17, 2022
PubMed

Insights

Pediatric patients with prior cardiovascular conditions face a higher risk of severe COVID-19. Cardiac arrest history in children under 12 is linked to increased COVID-19 severity and morbidity.

Area of Science:

  • Cardiology
  • Pediatric Infectious Diseases
  • Public Health

Background:

  • Identifying associations between severe COVID-19 and cardiovascular conditions in pediatric patients is crucial for informing treatment strategies.
  • Previous research has highlighted the vulnerability of children with underlying health issues to severe infectious diseases.

Purpose of the Study:

  • To assess the association between pre-existing cardiovascular conditions and the severity of COVID-19 in pediatric patients.
  • To identify specific cardiovascular conditions that may increase the risk of severe outcomes in children infected with SARS-CoV-2.

Main Methods:

  • A retrospective cohort study utilized electronic health records from 85 US health systems (March 2020-January 2021).
  • Included were pediatric patients (2 months to 17 years) with confirmed COVID-19 or SARS-CoV-2 exposure.
  • Logistic regression analysis examined associations between 26 cardiovascular conditions (diagnosed pre-COVID-19) and severe COVID-19 outcomes (need for oxygen or in-hospital death).

Main Results:

  • The study analyzed 171,416 pediatric patients, with 9.96% experiencing severe COVID-19.
  • Several cardiovascular conditions were significantly associated with severe COVID-19, including cardiac arrest (OR, 9.92), cardiogenic shock (OR, 3.07), and heart surgery (OR, 3.04).
  • Pediatric patients with a history of cardiac arrest, particularly those younger than 12 years, showed a disproportionately higher risk of severe COVID-19.

Conclusions:

  • Pre-existing cardiovascular conditions are associated with increased severity of COVID-19 in pediatric patients in the US.
  • Children younger than 12 years with a history of cardiac arrest may face heightened morbidity from COVID-19.
  • These findings underscore the importance of cardiovascular health assessment in pediatric COVID-19 management.
Abstract

Related Concept Videos

Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
49
Pulmonary Hypertension: Classification and Pathogenesis01:30

Pulmonary Hypertension: Classification and Pathogenesis

Pulmonary hypertension (PH) is a severe health condition in which the mean pulmonary arterial pressure increases to 25 mmHg or more, even when the body is at rest. This high pressure in the blood vessels that transport blood from the heart to the lungs can cause various symptoms, including shortness of breath, can lead to right heart failure, and significantly affect the overall quality of life.
There are various classifications for PH, each relating to different underlying causes and also...
302
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
79
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
71
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
36
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
58